Rh2E2 was unraveled to suppress tumor growth via down-regulation of metabolic enzymes for energy production; suppression of oncogenic proteins for cancer cell invasion, metastasis, proliferation and cell cycle progression; and activation of ERK-p53/-Egr1 signaling and inhibition of the Skp2 autoinduction loop for cell cycle arrest. This evidence concerns the gene TP53 and cancer.